AROI-ESTRO GYN Teaching Course

Patient characteristics

Characteristics

Number of patients (%)

Median age (years-range)

46 (10-74)

Tumor stage (1987 FIGO classification) IB2

79 (33%) 10 (5%) 121 (50%)

88 %

IIA IIB

IIIA IIIB IVA

6 (3%) 16 (7%) 5 (2%)

Histologic subtype Squamous Cell Carcinoma

199 (84%) 35 (15%)

Adenocarcinoma Adenosquamous

1 1 1

Clear cell adenocarcinoma Glassy cell adenocarcinoma

Pelvic node uptake(s) during PET imaging No

187 (79%) 50 (21%)

Yes

Size of the biggest para-aortic nodes involved

< 5 mm > 5 mm

13 16

Duration of the CRT (including brachytherapy)* < 55 days > 55 days

161 (68%) 75 (32%)

Median delay between procedures (days-range) PET/CT-para-aortic surgery**

14 (1-49) 35 (6-76) 27 (3-60)

PET/CT-Chemoradition therapy** Surgery-Chemoradiation therapy***

29 (11%) PA+ : False negative rate